跳至主要内容
临床试验/IRCT138710221542N1
IRCT138710221542N1已完成2 期

Comparison of two regimens of fluconazol 200 mg and 400 mg daily in the treatment of cutaneous lieshmaniasis

Shiraz University of Medical Scienses0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 70 years(—)
性别
All

入选标准

  • age over 12 years, positive PCR for leishmanisis and no treatment in two months ago, duration of disease is lower than 4 months.
  • Exclusion criteria: pregnancy, breast feeding, possibility of pregnancy in future, number of lesion over ten, history of liver disease and high BUN or Cr.

排除标准

  • 未提供

研究者

发起方
Shiraz University of Medical Scienses

相似试验

Comparison of two regimens of fluconazol in... | 临床试验